ATARA BIOTHERAPEUTICS, INC. Finance Lease, Liability, Noncurrent
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Finance Lease, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2025-03-07
- 2024-12-31: Finance Lease, Liability, Noncurrent $0.00.
- 2022-09-30: Finance Lease, Liability, Noncurrent $3.76M.
- 2022-06-30: Finance Lease, Liability, Noncurrent $3.97M.
- 2021-12-31: Finance Lease, Liability, Noncurrent $29.00K.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2022-09-30 | $3.76M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.97M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $29.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $149.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $244.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $85.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $141.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $196.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |